Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure

• Conditions: Chronic Heart Failure
• Interventions: Drug: HTEA

• Registration Number: NCT02292030
• Lead Sponsor: Harbin Medical University

Brief Summary

The purpose of this study is to explore the efficacy of low energy cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Detailed Description

The purpose of this study is to explore the efficacy of low energy (30J) cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Study Timeline

• Status Verified: 2014-11
• Study Start: 2014-11
• Study First Submitted: 2014-11-09
• Study First Submitted QC: 2014-11-12
• Last Update Submitted: 2014-11-12
• Study First Posted: 2014-11-17
• Last Update Posted: 2014-11-17
• Primary Completion: 2015-10
• Study Completion: 2015-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• congestive heart failure accompanied by atrial fibrillation.

Exclusion Criteria

• Valvular heart diseases.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
cardioversion+HTEA	HTEA	Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion+HTEA.
only cardioversion	HTEA	Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion, but not with HTEA.

Primary Outcome Measures

Name	Time	Method
recurrence of atrial fibrillation	1 year

Trial Locations

Locations (2)

Ren Xiaohui; 🇨🇳 Harbin, Heilongjiang, China

the first affiliated hospital of Harbin Medical University; 🇨🇳 Harbin, Heilongjiang, China